Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea.
Gang Kyu KimYoung Heun JoJong Soo LeeHyun Ho HanWon-Sik HamWon Sik JangJi Eun HeoPublished in: Investigative and clinical urology (2024)
Similar DFS outcome between high-risk and very high-risk patients were observed based on short-term results in Korea. This finding is crucial for clinical practice; however, studies analyzing more patients and long-term outcomes are needed.